Abstract
Chronic kidney disease (CKD) is associated with complex disturbances in hemostasis that may increase susceptibility to both bleeding and thrombotic complications. Hemodialysis, an essential treatment for advanced CKD, may further influence hematological and coagulation measurements through extracorporeal blood circulation, fluid removal, and anticoagulation. This observational study assessed changes in selected hematological and coagulation parameters immediately before and after a single hemodialysis session. Thirty-two patients receiving maintenance hemodialysis at Al-Fallujah Teaching Hospital were enrolled, and paired blood specimens were analyzed using complete blood count measurements and routine coagulation assays, including prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, and D-dimer. Most hematological comparisons were based on 31 paired measurements, whereas coagulation parameters were available for 32 participants. WBC and neutrophil counts, RBC count, hemoglobin, and hematocrit showed statistically significant post-dialysis increases in the reported analyses. Platelet count and routine platelet indices showed no significant differences. PT and APTT decreased slightly, while fibrinogen and D-dimer increased modestly; none of these coagulation differences reached statistical significance. These results suggest that one hemodialysis session is associated with selective short-term changes in circulating blood-cell measurements, whereas conventional coagulation indices remained relatively stable in this small cohort. Larger studies that document anticoagulation, fluid removal, and additional measures of platelet and coagulation function are warranted to clarify the mechanisms and clinical relevance of these findings.
Keywords: chronic kidney disease; hemodialysis; hemostasis; coagulation; platelets; D-dimer
Abstract
Chronic kidney disease (CKD) is associated with complex disturbances in hemostasis that may increase susceptibility to both bleeding and thrombotic complications. Hemodialysis, an essential treatment for advanced CKD, may further influence hematological and coagulation measurements through extracorporeal blood circulation, fluid removal, and anticoagulation. This observational study assessed changes in selected hematological and coagulation parameters immediately before and after a single hemodialysis session. Thirty-two patients receiving maintenance hemodialysis at Al-Fallujah Teaching Hospital were enrolled, and paired blood specimens were analyzed using complete blood count measurements and routine coagulation assays, including prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, and D-dimer. Most hematological comparisons were based on 31 paired measurements, whereas coagulation parameters were available for 32 participants. WBC and neutrophil counts, RBC count, hemoglobin, and hematocrit showed statistically significant post-dialysis increases in the reported analyses. Platelet count and routine platelet indices showed no significant differences. PT and APTT decreased slightly, while fibrinogen and D-dimer increased modestly; none of these coagulation differences reached statistical significance. These results suggest that one hemodialysis session is associated with selective short-term changes in circulating blood-cell measurements, whereas conventional coagulation indices remained relatively stable in this small cohort. Larger studies that document anticoagulation, fluid removal, and additional measures of platelet and coagulation function are warranted to clarify the mechanisms and clinical relevance of these findings.
Keywords: chronic kidney disease; hemodialysis; hemostasis; coagulation; platelets; D-dimer
References
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.
“KDIGO 2024 Clinical Practice Guideline for the Evaluation and
Management of Chronic Kidney Disease.” Kidney International,
vol. 105, suppl. 4, 2024, pp. S117–S314. https://kdigo.org/guidelines/ckd-evaluation-and-management/.
- GBD 2023 Chronic Kidney Disease Collaborators. “Global, Regional, and
National Burden of Chronic Kidney Disease in Adults, 1990–2023, and Its
Attributable Risk Factors: A Systematic Analysis for the Global Burden
of Disease Study 2023.” The Lancet, vol. 406, no. 10518, 2025,
pp. 2461–2482. https://doi.org/10.1016/S0140-6736(25)01853-7.
- Baaten, Constance C. F. M. J., et al. “Platelet Function in CKD: A
Systematic Review and Meta-Analysis.” Journal of the American
Society of Nephrology, vol. 32, no. 7, 2021, pp. 1583–1598. https://doi.org/10.1681/ASN.2020101440.
- Lutz, Jens, et al. “Haemostasis in Chronic Kidney Disease.”
Nephrology Dialysis Transplantation, vol. 29, no. 1, 2014, pp.
29–40. https://doi.org/10.1093/ndt/gft209.
- Hornig, Carsten, et al. “Hemoincompatibility in Hemodialysis-Related
Therapies and Their Health Economic Perspectives.” Journal of
Clinical Medicine, vol. 13, no. 20, 2024, article 6165. https://doi.org/10.3390/jcm13206165.
- Wattanakit, Keattiyoat, and Mary Cushman. “Chronic Kidney Disease and
Venous Thromboembolism: Epidemiology and Mechanisms.” Current
Opinion in Pulmonary Medicine, vol. 15, no. 5, 2009, pp.
408–412.
- Babitt, Jodie L., and Herbert Y. Lin. “Mechanisms of Anemia in CKD.”
Journal of the American Society of Nephrology, vol. 23, no. 10,
2012, pp. 1631–1634. https://doi.org/10.1681/ASN.2011111078.
- Jalal, Diana I., Michel Chonchol, and Giovanni Targher. “Disorders of
Hemostasis Associated with Chronic Kidney Disease.” Seminars in
Thrombosis and Hemostasis, vol. 36, no. 1, 2010, pp. 34–40.
- Raja, Veena, et al. “Impact of Haemodialysis on Coagulation Profile
in Chronic Kidney Disease.” Annals of Pathology and Laboratory
Medicine, vol. 8, no. 3, 2021, pp. A95–A99.
- Pavlou, Efthimia G., et al. “Coagulation Abnormalities in Renal
Pathology of Chronic Kidney Disease: The Interplay between Blood Cells
and Soluble Factors.” Biomolecules, vol. 11, no. 9, 2021,
article 1309. https://doi.org/10.3390/biom11091309.
- Pluta, Jan, et al. “Assessment of the Hemostatic Parameters and
Platelet Function on Thromboelastometry and Impedance Aggregometry in
Hemodialysis Patients Qualified for Kidney Transplantation: Preliminary
Report.” Transplantation Proceedings, vol. 48, no. 5, 2016, pp.
1431–1434. https://doi.org/10.1016/j.transproceed.2016.02.057.
- Mekawy, Mohamed A., Deena M. M. Habashy, and Waleed A. M. Abd
El-Mohsen. “Effect of Hemodialysis on Platelet Function in End-Stage
Renal Disease Egyptian Patients Using In Vitro Closure Time Test
(PFA-100 Analyzer).” Platelets, vol. 26, no. 5, 2015, pp.
443–447. https://doi.org/10.3109/09537104.2014.931569.
- World Health Organization. WHO Guidelines on Drawing Blood: Best
Practices in Phlebotomy. WHO, 2010. https://www.who.int/publications-detail-redirect/9789241599221.
- Lippi, Giuseppe, Gian Luca Salvagno, Giorgio Brocco, and Gian Cesare
Guidi. “Preanalytical Variability in Laboratory Testing: Influence of
the Blood Drawing Technique.” Clinical Chemistry and Laboratory
Medicine, vol. 43, no. 3, 2005, pp. 319–325. https://doi.org/10.1515/CCLM.2005.055.
- Kitchen, Steve, et al. “International Council for Standardisation in
Haematology (ICSH) Recommendations for Collection of Blood Samples for
Coagulation Testing.” International Journal of Laboratory
Hematology, vol. 43, no. 4, 2021, pp. 571–580. https://doi.org/10.1111/ijlh.13584.
- Gosselin, Robert C., and Richard A. Marlar. “Preanalytical Variables
in Coagulation Testing: Setting the Stage for Accurate Results.”
Seminars in Thrombosis and Hemostasis, vol. 45, no. 5, 2019,
pp. 433–448. https://doi.org/10.1055/s-0039-1692700.
- BIOLABO. BIO-TP Prothrombin Time and BIO-CK APTT Kaolin:
Instructions for Use. BIOLABO Diagnostics, n.d.
- BIOLABO. BIO-FIBRI Fibrinogen: Instructions for Use. BIOLABO
Diagnostics, n.d.
- Getein Biotech. D-Dimer Fast Test Kit (Immunofluorescence Assay):
Instructions for Use. Getein Biotech, n.d.
- Zybio Inc. Hematology Analyzer Operation Manual: Models Z5, Z50,
Z51, and Z52. Zybio Inc., n.d.
- Goyoneche Linares, Gabriela, et al. “Leukocyte Dysregulation and
Biochemical Alterations in End-Stage Kidney Disease Patients Under
Hemodialysis.” Diseases, vol. 13, no. 4, 2025, article 90. https://doi.org/10.3390/diseases13040090.
- Sagheb, Mohammad Mahdi, et al. “Comparison of Hemoglobin Levels
Before and After Hemodialysis and Their Effects on Erythropoietin Dosing
and Cost.” Nephro-Urology Monthly, vol. 8, no. 4, 2016, article
e38495.
- Martin, Josette Caroline, et al. “Hematological and Urine Analysis
Changes in Pre and Post Hemodialysis Patients with Chronic Kidney
Disease in a Tertiary Care Hospital in Puducherry–South India.” The
Bioscan, vol. 20, supplement 2, 2025, pp. 664–670.
- Kaw, Dinkar, and Deepak Malhotra. “Platelet Dysfunction and End-Stage
Renal Disease.” Seminars in Dialysis, vol. 19, no. 4, 2006, pp.
317–322.
- Hernaningsih, Yetti, Widodo Widodo, and Koko Aprianto. “Comparison of
PPT and APTT in Pre and Post-Hemodialysis Patients as the
Heparin-Exposed Effect.” Folia Medica Indonesiana, vol. 55, no.
3, 2019, pp. 166–170.
How to cite:
Iman Sami AbdulAmeer, Noor Thamer Hamood, Roaa Waleed Dawood Hussein, Anwar Khalil Ismael, Ghaith I.S. Alwani. Effect of a Single Hemodialysis Session on Hemostatic Function in Patients With Chronic Kidney Disease. Revista Cultura Científica, 2026 Issue 24. pg. 1851-1865.
Publication History
-
Received: 09/06/2026
-
Accepted: 01/10/2026
-
Published: 13/10/2026
Copyright © 2026, Iman Sami AbdulAmeer, Noor Thamer Hamood, Roaa Waleed Dawood Hussein, Anwar Khalil Ismael, Ghaith I.S. Alwani. Published by Revista Cultura Científica. This article is published as open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) license (
http://creativecommons.org/licenses/by/4.0/).